Immunopathological changes during immunosuppressive treatment of glomerulonephritis in systemic lupus erythematosus.
D000328:Adult; D000818:Animals; D000906:Antibodies; D000941:Antigens; D001379:Azathioprine / Q000627:therapeutic use*; D001706:Biopsy; D003165:Complement System Proteins; D004359:Drug Therapy, Combination; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007106:Immune Sera; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007668:Kidney / Q000473:pathology*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D008297:Male; D008856:Microscopy, Fluorescence; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D011817:Rabbits / Q000276:immunology; D005719:gamma-Globulins
D000906:Antibodies; D000941:Antigens; D007106:Immune Sera; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D005719:gamma-Globulins; D003165:Complement System Proteins; D001379:Azathioprine; D011241:Prednisone